Ganesh Venkataraman Kaundinya, Senior V.P, Research at MOMENTA PHARMACEUTICALS INC (MNTA), sold 1,048 shares at $14.40 ($14K) on 2016-11-22, disclosed to the SEC on 2016-11-23.
Scheduled sale ($14k) by Senior V.P, Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.45 | 396 | $5K | 37.2% |
| 2 | $13.45 | 425 | $6K | 39.9% |
| 3 | $14.40 | 227 | $3K | 22.8% |
| Total | $13.66 avg | 1,048 | $14K | 100% |
| Filing → |
| MNTA | SELL | 2018-08-10 | $18K | — | Filing → |
| MNTA | SELL | 2018-05-23 | $9K | — | Filing → |
| MNTA | SELL | 2018-05-14 | $8K | — | Filing → |